Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H8O3S |
Molecular Weight | 208.234 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=C2C=CC=CC2=CC=C1
InChI
InChIKey=PSZYNBSKGUBXEH-UHFFFAOYSA-N
InChI=1S/C10H8O3S/c11-14(12,13)10-7-3-5-8-4-1-2-6-9(8)10/h1-7H,(H,11,12,13)
Molecular Formula | C10H8O3S |
Molecular Weight | 208.234 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Determination of naphthalenesulfonic acid isomers by large-volume on-line derivatization and gas chromatography-mass spectrometry. | 2001 Aug 17 |
|
Characterization of a partially folded intermediate of stem bromelain at low pH. | 2002 Jan |
|
Final report on the amended safety assessment of sodium polynaphthalenesulfonate and sodium naphthalenesulfonate. | 2003 |
|
The unique aromatic catabolic genes in sphingomonads degrading polycyclic aromatic hydrocarbons (PAHs). | 2003 Feb |
|
Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate. | 2003 Jun 13 |
|
Trifluoroethanol-induced "molten globule" state in stem bromelain. | 2003 May 15 |
|
Analysis of naphthalenesulfonate compounds by cyclodextrin-mediated capillary electrophoresis with sample stacking. | 2003 May 9 |
|
Separation and migration behavior of positional and structural naphthalenesulfonate isomers by cyclodextrin-mediated capillary electrophoresis. | 2004 Apr 9 |
|
Inactivation of NADP+-dependent isocitrate dehydrogenase by lipid peroxidation products. | 2004 Mar |
|
Ozonation of naphthalenesulphonic acid in the aqueous phase in the presence of basic activated carbons. | 2004 Oct 12 |
|
Low versus high molecular weight poly(ethylene glycol)-induced states of stem bromelain at low pH: stabilization of molten globule and unfolded states. | 2006 Apr 5 |
|
A chromatographic estimate of the degree of surface heterogeneity of reversed-phase liquid chromatography packing materials. II-Endcapped monomeric C18-bonded stationary phase. | 2006 Jan 20 |
|
Identification and functional analysis of the genes for naphthalenesulfonate catabolism by Sphingomonas xenophaga BN6. | 2006 Jul |
|
Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature. | 2006 Sep 29 |
|
Native-like tertiary structure in the Mucor miehei lipase molten globule state obtained at low pH. | 2007 Mar |
|
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. | 2008 |
|
Membrane bioreactors for municipal wastewater treatment - a viable option to reduce the amount of polar pollutants discharged into surface waters? | 2008 Aug |
|
Detection of conformational changes in immunoglobulin G using isothermal titration calorimetry with low-molecular-weight probes. | 2008 Sep 15 |
|
Benzyl-tributyl-ammonium 6,7-dihydroxy-naphthalene-2-sulfonate. | 2009 Jan 17 |
|
Benzyl-tributyl-ammonium 4,6-dihydroxy-naphthalene-2-sulfonate. | 2009 Jan 17 |
|
Discovery and mechanistic study of a class of protein arginine methylation inhibitors. | 2010 Aug 26 |
|
How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. | 2010 Jun 13 |
|
Interaction of imidacloprid with hemoglobin by fluorescence and circular dichroism. | 2010 May |
|
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors. | 2010 Nov |
|
Physiology and biochemistry of reduction of azo compounds by Shewanella strains relevant to electron transport chain. | 2010 Oct |
|
Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative. | 2010 Oct |
|
Biofoams and natural protein surfactants. | 2010 Oct |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:54:56 GMT 2023
by
admin
on
Fri Dec 15 18:54:56 GMT 2023
|
Record UNII |
0SJH61WM2J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
85-47-2
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
0SJH61WM2J
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
Naphthalene-1-sulfonic acid
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
6812
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
201-610-1
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
m7731
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID7048033
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
30895
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | |||
|
1442718
Created by
admin on Fri Dec 15 18:54:56 GMT 2023 , Edited by admin on Fri Dec 15 18:54:56 GMT 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|